Ezrin is a specific and direct target of protein tyrosine phosphatase PRL-3

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1783, Issue 2, 2008, Pages 334-344

  Forte, Eleonora ^a,b   Orsatti, Laura ^a   Talamo, Fabio ^a   Barbato, Gaetano ^a   De Francesco, Raffaele ^a   Tomei, Licia ^a  

^a IRBM   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

ERM proteins; Phosphorylation; PTP; RNA interference; Substrate identification

Indexed keywords

CELL PROTEIN; EZRIN; PHOSPHATASE OF REGENERATING LIVER 3; PROTEIN TYROSINE PHOSPHATASE; RNA; THREONINE; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CELL STRAIN HCT116; COLON CANCER; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; TUMOR GROWTH; VASCULARIZATION;

CATALYSIS; CYTOSKELETAL PROTEINS; ENDOTHELIAL CELLS; HCT116 CELLS; HUMANS; MUTANT PROTEINS; NEOPLASM PROTEINS; PHOSPHORYLATION; PHOSPHOTHREONINE; PHOSPHOTYROSINE; PROTEIN TYROSINE PHOSPHATASES; RNA INTERFERENCE; SUBSTRATE SPECIFICITY; TETRADECANOYLPHORBOL ACETATE;

EID: 38349095940     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2007.11.004     Document Type: Article

References (40)

1. Andersen J.N., Jansen P.G., Echwald S.M., Mortensen O.H., Fukada T., Del Vecchio R., Tonks N.K., and Moller N.P. A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage. Faseb J. 18 (2004) 8-30
2. Alonso A., Sasin J., Bottini N., Friedberg I., Osterman A., Godzik A., Hunter T., Dixon J., and Mustelin T. Protein tyrosine phosphatases in the human genome. Cell 117 (2004) 699-711
3. Stephens B.J., Han H., Gokhale V., and Von Hoff D.D. PRL phosphatases as potential molecular targets in cancer. Mol. Cancer Ther. 4 (2005) 1653-1661
4. Matter W.F., Estridge T., Zhang C., Belagaje R., Stancato L., Dixon J., Johnson B., Bloem L., Pickard T., Donaghue M., Acton S., Jeyaseelan R., Kadambi V., and Vlahos C.J. Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling. Biochem. Biophys. Res. Commun. 283 (2001) 1061-1068
5. Zeng Q., Hong W., and Tan Y.H. Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1. Biochem. Biophys. Res. Commun. 244 (1998) 421-427
6. Zeng Q., Si X., Horstmann H., Xu Y., Hong W., and Pallen C.J. Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome. J. Biol. Chem. 275 (2000) 21444-21452
7. Saha S., Bardelli A., Buckhaults P., Velculescu V.E., Rago C., St Croix B., Romans K.E., Choti M.A., Lengauer C., Kinzler K.W., and Vogelstein B. A phosphatase associated with metastasis of colorectal cancer. Science 294 (2001) 1343-1346
8. Bardelli A., Saha S., Sager J.A., Romans K.E., Xin B., Markowitz S.D., Lengauer C., Velculescu V.E., Kinzler K.W., and Vogelstein B. PRL-3 expression in metastatic cancers. Clin. Cancer Res. 9 (2003) 5607-56015
9. Kato H., Semba S., Miskad U.A., Seo Y., Kasuga M., and Yokozaki H. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases. Clin. Cancer Res. 10 (2004) 7318-7328
10. Schwering I., Brauninger A., Distler V., Jesdinsky J., Diehl V., Hansmann M.L., Rajewsky K., and Kuppers R. Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes. Mol. Med. 9 (2003) 85-95
11. Wu X., Zeng H., Zhang X., Zhao Y., Sha H., Ge X., Zhang M., Gao X., and Xu Q. Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. Am. J. Pathol. 164 (2004) 2039-2054
12. Radke I., Gotte M., Kersting C., Mattsson B., Kiesel L., and Wulfing P. Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer. Br. J. Cancer 95 (2006) 347-354
13. Miskad U.A., Semba S., Kato H., and Yokozaki H. Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis. Pathobiology 71 (2004) 176-184
14. Peng L., Ning J., Meng L., and Shou C. The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer. J. Cancer Res. Clin. Oncol. 130 (2004) 521-526
15. Zeng Q., Dong J.M., Guo K., Li J., Tan H.X., Koh V., Pallen C.J., Manser E., and Hong W. PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. Cancer Res. 63 (2003) 2716-2722
16. Guo K., Li J., Tang J.P., Koh V., Gan B.Q., and Zeng Q. Catalytic domain of PRL-3 plays an essential role in tumor metastasis: formation of PRL-3 tumors inside the blood vessels. Cancer Biol. Ther. 3 (2004) 945-951
17. Li Z., Zhan W., Wang Z., Zhu B., He Y., Peng J., Cai S., and Ma J. Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis. Biochem. Biophys. Res. Commun. 348 (2006) 229-237
18. Parker B.S., Argani P., Cook B.P., Liangfeng H., Chartrand S.D., Zhang M., Saha S., Bardelli A., Jiang Y., St Martin T.B., Nacht M., Teicher B.A., Klinger K.W., Sukumar S., and Madden S.L. Alterations in vascular gene expression in invasive breast carcinoma. Cancer Res. 64 (2004) 7857-7866
19. Fiordalisi J.J., Keller P.J., and Cox A.D. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Cancer Res. 66 (2006) 3153-3161
20. Liang F., Liang J., Wang W.Q., Sun J.P., Udho E., and Zhang Z.Y. PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation. J. Biol. Chem. 282 (2007) 5413-5419
21. Peng L., Jin G., Wang L., Guo J., Meng L., and Shou C. Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3. Biochem. Biophys. Res. Commun. 342 (2006) 179-183
22. Bretscher A., Edwards K., and Fehon R.G. ERM proteins and merlin: integrators at the cell cortex. Nat. Rev. Mol. Cell Biol. 3 (2002) 586-599
23. Bretscher A., Reczek D., and Berryman M. Ezrin: a protein requiring conformational activation to link microfilaments to the plasma membrane in the assembly of cell surface structures. J. Cell Sci. 110 Pt 24 (1997) 3011-3018
24. Crepaldi T., Gautreau A., Comoglio P.M., Louvard D., and Arpin M. Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells. J. Cell Biol. 138 (1997) 423-434
25. Srivastava J., Elliott B.E., Louvard D., and Arpin M. Src-dependent Ezrin phosphorylation in adhesion-mediated signaling. Mol. Biol. Cell 16 (2005) 1481-1490
26. Matsui T., Maeda M., Doi Y., Yonemura S., Amano M., Kaibuchi K., and Tsukita S. Rho-kinase phosphorylates COOH-terminal threonines of Ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J. Cell Biol. 140 (1998) 647-657
27. Rouleau C., Roy A., St Martin T., Dufault M.R., Boutin P., Liu D., Zhang M., Puorro-Radzwill K., Rulli L., Reczek D., Bagley R., Byrne A., Weber W., Roberts B., Klinger K., Brondyk W., Nacht M., Madden S., Burrier R., Shankara S., and Teicher B.A. Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function. Mol. Cancer Ther. 5 (2006) 219-229
28. Koss M., Pfeiffer G.R., Wang Y., Thomas S.T., Yerukhimovich M., Gaarde W.A., Doerschuk C.M., and Wang Q. Ezrin/radixin/moesin proteins are phosphorylated by TNF-alpha and modulate permeability increases in human pulmonary microvascular endothelial cells. J. Immunol. 176 (2006) 1218-1227
29. Khanna C., Wan X., Bose S., Cassaday R., Olomu O., Mendoza A., Yeung C., Gorlick R., Hewitt S.M., and Helman L.J. The membrane-cytoskeleton linker Ezrin is necessary for osteosarcoma metastasis. Nat. Med. 10 (2004) 182-186
30. Yu Y., Khan J., Khanna C., Helman L., Meltzer P.S., and Merlino G. Expression profiling identifies the cytoskeletal organizer Ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat. Med. 10 (2004) 175-181
31. Louvet-Vallee S. ERM proteins: from cellular architecture to cell signaling. Biol. Cell 92 (2000) 305-316
32. Hishiya A., Ohnishi M., Tamura S., and Nakamura F. Protein phosphatase 2C inactivates F-actin binding of human platelet moesin. J. Biol. Chem. 274 (1999) 26705-26712
33. Fukata Y., Kimura K., Oshiro N., Saya H., Matsuura Y., and Kaibuchi K. Association of the myosin-binding subunit of myosin phosphatase and moesin: dual regulation of moesin phosphorylation by Rho-associated kinase and myosin phosphatase. J. Cell Biol. 141 (1998) 409-418
34. Kozlov G., Cheng J., Ziomek E., Banville D., Gehring K., and Ekiel I. Structural insights into molecular function of the metastasis-associated phosphatase PRL-3. J. Biol. Chem. 279 (2004) 11882-11889
35. Kishore R., Qin G., Luedemann C., Bord E., Hanley A., Silver M., Gavin M., Yoon Y.S., Goukassian D., and Losordo D.W. The cytoskeletal protein Ezrin regulates EC proliferation and angiogenesis via TNF-alpha-induced transcriptional repression of cyclin A. J. Clin. Invest. 115 (2005) 1785-1796
36. Ivetic A., and Ridley A.J. Ezrin/radixin/moesin proteins and Rho GTPase signalling in leucocytes. Immunology 112 (2004) 165-176
37. Heiska L., and Carpen O. Src phosphorylates Ezrin at tyrosine 477 and induces a phosphospecific association between Ezrin and a kelch-repeat protein family member. J. Biol. Chem. 280 (2005) 10244-10252
38. Tran Quang C., Gautreau A., Arpin M., and Treisman R. Ezrin function is required for ROCK-mediated fibroblast transformation by the Net and Dbl oncogenes. Embo J. 19 (2000) 4565-4576
39. Elliott B.E., Meens J.A., SenGupta S.K., Louvard D., and Arpin M. The membrane cytoskeletal crosslinker Ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Res. 7 (2005) R365-R373
40. McClatchey A.I. Merlin and ERM proteins: unappreciated roles in cancer development?. Nat. Rev. Cancer 3 (2003) 877-883